G K PHARMA

Delhi, India Founded: 1985 • Age: 41 yrs
Distributes capsules and pellets to pharmaceutical industry in North India.

About G K PHARMA

G K PHARMA is a company based in Delhi (India) founded in 1985. It operates as a B2B. G K PHARMA offers products and services including Empty Hard Gelatin Capsules, HPMC Capsules, and Pellets. G K PHARMA operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

  • Headquarter Delhi, India
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website gkpharma.in
  • Legal Name Rohan Pharma Private Limited
  • Date of Incorporation 20 Dec, 1996
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Annual Revenue
    ₹95.01 Cr

    FY 2025 · +17% YoY

  • Net Profit
    ₹2.90 Cr

    FY 2025 · 3% margin

  • EBITDA
    ₹4.62 Cr

    FY 2025 · 5% margin

Products & Services of G K PHARMA

G K PHARMA offers a comprehensive portfolio of products and services, including Empty Hard Gelatin Capsules, HPMC Capsules, and Pellets.

Empty Hard Gelatin Capsules
Pharmaceutical Supplies

High-quality capsules for pharmaceutical formulations and packaging

HPMC Capsules
Pharmaceutical Supplies

Vegetable-based capsules for alternative medicine applications

Pellets
Pharmaceutical Supplies

Components used in drug formulation and delivery systems

Board of directors of Rohan Pharma Private Limited (G K PHARMA)

Rohan Pharma Private Limited is the primary company behind G K PHARMA. The board of Rohan Pharma Private Limited currently have 5 directors; the longest-serving is Anita Sardana, appointed in 1996.

DirectorDesignationAppointedTenureEntity
Anita Sardana
DIN 00242442
Director20 Dec 199629 yrs 9 moRohan Pharma Private Limited
Gireesh Sardana
DIN 00242384
Whole-time director20 Dec 199629 yrs 9 moRohan Pharma Private Limited
Rohan Sardana
DIN 00242483
Whole-time director21 Dec 199629 yrs 9 moRohan Pharma Private Limited
Ankita Sardana
DIN 09193556
Director27 Jul 20215 yrs 2 moRohan Pharma Private Limited
Aryavir Sardana
DIN 10911162
Additional Director17 Jan 20251 yr 8 moRohan Pharma Private Limited

Financials of G K PHARMA

Figures of Rohan Pharma Private Limited, the primary company behind G K PHARMA, for FY 2025. Revenue was ₹95.01 Cr (+17% year on year). Net profit was ₹2.90 Cr (3% margin). EBITDA was ₹4.62 Cr (5% margin). Revenue has grown at a compounded annual rate of +1% over three years and +27% over five years.

  • ₹95.01 CrRevenue · FY 2025 · +17% YoY
  • ₹2.90 CrNet profit · 3% margin
  • ₹4.62 CrEBITDA · 5% margin
  • ₹1.46 CrPaid-up capital
  • +1%Revenue CAGR, 3 years
  • +27%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Rohan Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for G K PHARMA

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of G K PHARMA

G K PHARMA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
amerisourcebergen.com1985Chesterbrook, United States–46,000
Pharmaceutical distribution and supply chain services are provided globally.
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$11.53M161
Provider of medical equipment, devices, and drugs distribution services
mahaveermedi.com2016Bengaluru, India–588
Serves as a distributor of a wide range of pharmaceutical drugs.
dipnapharmachem.com2011Ahmedabad, India––
Distributor of pharmaceutical raw materials
Premium access

Detailed competitors of G K PHARMA

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to G K PHARMA

10 companies that operate in the same segment as G K PHARMA (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about G K PHARMA

G K PHARMA was founded in 1985.

G K PHARMA is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

The primary company behind G K PHARMA, Rohan Pharma Private Limited, reported revenue of β‚Ή95.01 Cr for FY 2025, up 17% year on year.

G K PHARMA is a distributor of Empty Hard Gelatin Capsules and HPMC Capsules, serving over 400 customers in the pharmaceutical sector since 1985. It operates from multiple locations in India, focusing on high-quality products and expanding its business through distribution networks. The company emphasizes customer needs and industry demands, providing solutions for capsules and pellets while maintaining strong leadership.

G K PHARMA's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.

G K PHARMA offers Empty Hard Gelatin Capsules, HPMC Capsules, and Pellets.

G K PHARMA operates through Rohan Pharma Private Limited.

The legal entities of G K PHARMA currently have 5 directors, including Ankita Sardana, Anita Sardana, Gireesh Sardana and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available